Lemon balm (Melissa officinalis) is a perennial herb native to the Mediterranean and Central Asia, cultivated worldwide for culinary, medicinal, and aromatic purposes. It has been used in European herbal medicine since at least the Middle Ages, with documented use by physicians including Paracelsus and later in the London Dispensatory. Today it is one of the most studied calming botanicals in phytomedicine, with a meaningful body of human clinical trial data.

Lemon balm's primary anxiolytic and sedative mechanisms appear to involve inhibition of GABA transaminase — the enzyme that breaks down the inhibitory neurotransmitter GABA — thereby increasing GABAergic tone in the brain. Rosmarinic acid, its best-studied active compound, has demonstrated this GABA transaminase inhibitory effect in vitro, and this mechanism is consistent with lemon balm's observed reduction of anxiety and promotion of sleep in human trials. Additional mechanisms include nicotinic and muscarinic acetylcholine receptor binding activity, which may account for observed pro-cognitive effects, as well as monoamine modulation and antioxidant activity from flavonoids.

Standardized extracts in capsule or tablet form offer the most consistent dosing and are what most clinical trials use. Liquid tinctures and glycerites are absorbed quickly and may be suitable for acute use. Herbal tea provides a milder effect and is suitable for mild stress or sleep support but delivers substantially lower doses of active compounds. Topical creams containing lemon balm extract have been specifically studied for cold sores (oral herpes).

• Anxiety
• Sleep disturbance / insomnia
• Cognitive performance and stress
• Cold sores (oral herpes)
• Menstrual cramps and PMS mood symptoms

• Recurrence interval extension in oral herpes (topical use may prolong time between outbreaks — supported by Wölbling & Leonhardt 1994 patient reports, though larger confirmatory RCTs are lacking)

• Drowsiness or sedation (particularly at doses above 600 mg or when combined with other sedatives)
• Nausea or stomach upset (most common at higher doses, reduced by taking with food)
• Headache (reported in some trials at higher doses)
• Dizziness (uncommon, dose-dependent)
• Possible thyroid hormone suppression with chronic high-dose use (theoretical concern based on in vitro data; monitor in individuals with thyroid conditions)
• Allergic skin reaction (rare; more common with topical application in sensitive individuals)

• Recommended daily: 300–600 mg of standardized extract (standardized to ≥7% rosmarinic acid) per day, typically divided into 1–2 doses. For sleep: 600 mg taken 30–60 minutes before bed. For anxiety/cognitive support: 300 mg taken 1–2 times daily. Herbal tea: 1.5–4.5 g dried herb steeped per cup, up to 3 cups daily (lower and less consistent active compound delivery).
• Best time of day: For sleep support: 30–60 minutes before bedtime. For daytime anxiety or cognitive support: morning or early afternoon to avoid interference with nighttime alertness. Avoid high doses late at night if also taking other sedatives.
• With or without food: Can be taken with or without food; taking with a small meal may reduce the likelihood of nausea, particularly with higher doses.
• Time to effect: Acute calming or mood effects may be felt within 1–3 hours of a single dose. Consistent improvement in sleep or anxiety typically requires 2–4 weeks of daily use.
• How long to take it: Short-term use of 4–8 weeks is well-supported by clinical trial data. For ongoing use, periodic breaks (e.g., 1–2 weeks off every 2–3 months) are a reasonable precaution given limited long-term safety data, though no evidence of harm with continuous use has been documented.